GSI 7916 (Epclusa sofosbuvir 400 mg / velpatasvir 100 mg)

Generic Name: sofosbuvir/velpatasvir

Pill with imprint GSI 7916 is Pink, Four-sided and has been identified as Epclusa sofosbuvir 400 mg / velpatasvir 100 mg. It is supplied by Gilead Sciences, Inc..

Epclusa is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. Epclusa sofosbuvir 400 mg / velpatasvir 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 7916

Epclusa

Generic Name

sofosbuvir/velpatasvir

Imprint

GSI 7916

Strength

sofosbuvir 400 mg / velpatasvir 100 mg

Color

Pink

Size

20.00 mm

Shape

Four-sided

Availability

Prescription only

Drug Class

Antiviral combinations

CSA Schedule

Not a controlled drug

Labeler / Supplier

Gilead Sciences, Inc.

National Drug Code (NDC)

61958-2201

Inactive Ingredients

alcohol, copovidone, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, water, titanium dioxide, polyethylene glycol 3350, magnesium silicate, ferric oxide red

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer